KesselADKlineMZingerMMcLaughlinDSilverPSwebergTM. The impact and statistical analysis of a multifaceted anticoagulation strategy in children supported on ECMO: performance and pitfalls. J Intensive Care Med. 2017;32(1):59–67.
2.
BembeaMMAnnichGRycusPOldenburgGBerkowitzIPronovostP. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med. 2013;14(2):e77–e88.
3.
LiverisABelloRAFriedmannP. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014;15(2):e72–e79.
4.
SievertAUberWLawsSCochranJ. Improvement in long-term ECMO by detailed monitoring of anticoagulation: a case report. Perfusion. 2011;26(1):59–64.
5.
Joshua BryantRParthak ProdhanMRichard FiserM. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study. Pediatr Crit Care Med. 2014;15(4):e175–e182.
